Totus Medicines

Ninety percent of diseases are considered undruggable, where a current drug target does not exist to treat the disease effectively. Totus systematically discovers covalent inhibitors to unlock treatments for cancer, autoimmune diseases, and infectious diseases. With the power of covalent chemistry and an AI-enabled high-throughput drug discovery platform, Totus is creating medicines for otherwise untreatable diseases.